Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,858.00
Bid: 6,847.00
Ask: 6,850.00
Change: 1.00 (0.01%)
Spread: 3.00 (0.04%)
Open: 6,800.00
High: 6,921.00
Low: 6,779.00
Yest. Close: 6,857.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Earnings, Trading Statements Calendar - Week Ahead

27 Jul 15 05:16

REPEAT: Earnings, Trading Statements Calendar - Week Ahead

24 Jul 15 15:15

Earnings, Trading Statements Calendar - Week Ahead

24 Jul 15 15:06

AstraZeneca chases biosimilar Avastin drug with Japanese group

By Ben Hirschler LONDON, July 24 (Reuters) - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin. Its new 50/50 joint venture

24 Jul 15 13:55

Earnings, Trading Statements Calendar - Week Ahead

24 Jul 15 05:15

Earnings, Trading Statements Calendar - Week Ahead

23 Jul 15 15:14

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Microsoft, Chipotle, Intuitive Surgical

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell in early trading on Wednesday after disappointing

22 Jul 15 14:25

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Intuitive Surgical, Biogen

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stock index futures fell on Wednesday as corporate earnings di

22 Jul 15 13:05

TOP NEWS SUMMARY: No Doubts For Policymakers To Keep UK Rates On Hold

22 Jul 15 10:20

LONDON BRIEFING: easyJet Shares Buck Down Market As It Beats Guidance

22 Jul 15 07:30

UPDATE 1-AstraZeneca suffers setback as drug fails in eye cancer

* Selumetinib fails in Phase III trial for uveal melanoma * Drug continues to be tested in lung, other cancers * 2020 consensus sales forecast for selumetinib $305 mln (Adds sales forecast, analyst comment, disease details) By Ben Hirschler LONDON, July 22 (Reuters) - As

22 Jul 15 07:26

Synairgen Says AstraZeneca Begins Phase IIa Trial In Severe Asthma

22 Jul 15 07:00

AstraZeneca drug selumetinib fails in uveal melanoma trial

LONDON, July 22 (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for uveal melanoma. The drugmaker said the setback would not affect other studies using the drug.

22 Jul 15 06:27

Astrazeneca Late Stage Selumetinib Combination Study Misses Endpoint

22 Jul 15 06:21

UPDATE 1-Bristol-Myers' Opdivo found effective in kidney cancer

(Adds details, analyst comment, shares) July 20 (Reuters) - Bristol-Myers Squibb Co said a late-stage trial of its drug, Opdivo, was stopped early after the immunotherapy was found to be effective in patients with the most common form of kidney cancer. The U.S. drugmaker said on Monda

20 Jul 15 13:38

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.